244 related articles for article (PubMed ID: 12925569)
1. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.
Huynh DP; Scoles DR; Nguyen D; Pulst SM
Hum Mol Genet; 2003 Oct; 12(20):2587-97. PubMed ID: 12925569
[TBL] [Abstract][Full Text] [Related]
2. Parkin promotes proteasomal degradation of synaptotagmin IV by accelerating polyubiquitination.
Kabayama H; Tokushige N; Takeuchi M; Kabayama M; Fukuda M; Mikoshiba K
Mol Cell Neurosci; 2017 Apr; 80():89-99. PubMed ID: 28254618
[TBL] [Abstract][Full Text] [Related]
3. Screening for mutations in synaptotagmin XI in Parkinson's disease.
Glass AS; Huynh DP; Franck T; Woitalla D; Müller T; Pulst SM; Berg D; Krüger R; Riess O
J Neural Transm Suppl; 2004; (68):21-8. PubMed ID: 15354386
[TBL] [Abstract][Full Text] [Related]
4. Parkin ubiquitinates and promotes the degradation of RanBP2.
Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
[TBL] [Abstract][Full Text] [Related]
5. Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology.
Wang C; Kang X; Zhou L; Chai Z; Wu Q; Huang R; Xu H; Hu M; Sun X; Sun S; Li J; Jiao R; Zuo P; Zheng L; Yue Z; Zhou Z
Nat Commun; 2018 Jan; 9(1):81. PubMed ID: 29311685
[TBL] [Abstract][Full Text] [Related]
6. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.
Tsai YC; Fishman PS; Thakor NV; Oyler GA
J Biol Chem; 2003 Jun; 278(24):22044-55. PubMed ID: 12676955
[TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
8. SEPT5_v2 is a parkin-binding protein.
Choi P; Snyder H; Petrucelli L; Theisler C; Chong M; Zhang Y; Lim K; Chung KK; Kehoe K; D'Adamio L; Lee JM; Cochran E; Bowser R; Dawson TM; Wolozin B
Brain Res Mol Brain Res; 2003 Oct; 117(2):179-89. PubMed ID: 14559152
[TBL] [Abstract][Full Text] [Related]
9. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the second C2 domain of synaptotagmin disrupt synaptic transmission at Drosophila neuromuscular junctions.
Mackler JM; Reist NE
J Comp Neurol; 2001 Jul; 436(1):4-16. PubMed ID: 11413542
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
[TBL] [Abstract][Full Text] [Related]
13. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
[TBL] [Abstract][Full Text] [Related]
14. Functional modulation of parkin through physical interaction with SUMO-1.
Um JW; Chung KC
J Neurosci Res; 2006 Nov; 84(7):1543-54. PubMed ID: 16955485
[TBL] [Abstract][Full Text] [Related]
15. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
[TBL] [Abstract][Full Text] [Related]
16. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
[TBL] [Abstract][Full Text] [Related]
17. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
Zhang Y; Gao J; Chung KK; Huang H; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13354-9. PubMed ID: 11078524
[TBL] [Abstract][Full Text] [Related]
18. Parkin accumulation in aggresomes due to proteasome impairment.
Junn E; Lee SS; Suhr UT; Mouradian MM
J Biol Chem; 2002 Dec; 277(49):47870-7. PubMed ID: 12364339
[TBL] [Abstract][Full Text] [Related]
19. Parkin interacts with the proteasome subunit alpha4.
Dächsel JC; Lücking CB; Deeg S; Schultz E; Lalowski M; Casademunt E; Corti O; Hampe C; Patenge N; Vaupel K; Yamamoto A; Dichgans M; Brice A; Wanker EE; Kahle PJ; Gasser T
FEBS Lett; 2005 Jul; 579(18):3913-9. PubMed ID: 15987638
[TBL] [Abstract][Full Text] [Related]
20. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
